Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 80, n° 6
pages 1778-1779 (juin 2019)
Doi : 10.1016/j.jaad.2018.11.037
Research Letters

Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
 

Lucy Y. Liu, MD, Brett A. King, MD, PhD
 Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 

Reprint requests: Brett A. King, MD, PhD, Department of Dermatology, Yale University School of Medicine, PO Box 208059, New Haven, CT 06520Department of DermatologyYale University School of MedicinePO Box 208059New HavenCT06520

 Funding sources: Supported by The Ranjini and Ajay Poddar Resource Fund for Dermatologic Diseases Research (to Dr King) and Yale University School of Medicine Medical Research Fellowship and the Taylor Opportunity Student Research Fellowship (to Dr Liu).
 Conflicts of interest: Dr King is an investigator for Concert Pharmaceuticals Inc, Eli Lilly and Company, and Pfizer Inc; he is a consultant to and/or has served on advisory boards for Aclaris Therapeutics, Arena Pharmaceuticals, Concert Pharmaceuticals Inc, Dermavant Sciences, Eli Lilly and Company, and Pfizer Inc; and he is on speakers bureau for Pfizer Inc, Regeneron, and Sanofi Genzyme. Dr Liu has no conflicts of interest to disclose.


Top of the page

© 2018  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@